CAR Target discovery

CBTN data will be used to identify new treatment targets for a form of immunotherapy called chimeric antigen receptor (CAR) T cell therapy.
Our analysis seeks to identify novel targets and subtypes in high grade brain tumors. We plan on using imaging data to identify imaging differences at time of diagnosis that might inform further study.